Home › Trial NCT07041320
Oral Metronomic Vinorelbine and PD-1 Inhibitors in Elderly Non-small Cell Lung Cancer
- Trial IDNCT07041320
- StatusRecruiting
- PhaseN/A
- Study typeObservational
- SponsorAnhui Chest Hospital
- Enrollment40
- Start date2023-06-15
- ConditionsLung Cancer (NSCLC) · Elderly (People Aged 65 or More)
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.